Ever Supreme Bio Technology Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentage	n/a
CEO tenure	no data
CEO ownership	n/a
Management average tenure	no data
Board average tenure	no data

Recent management updates

Recent updates

Is Ever Supreme Bio Technology's (GTSM:6712) Share Price Gain Of 126% Well Earned?

Mar 11

We're Hopeful That Ever Supreme Bio Technology (GTSM:6712) Will Use Its Cash Wisely

Jan 13

If You Had Bought Ever Supreme Bio Technology (GTSM:6712) Shares A Year Ago You'd Have Earned 24% Returns

Nov 17

CEO

Ever Supreme Bio Technology has no CEO, or we have no data on them.

Ever Supreme Bio Technology Management

Management criteria checks 0/4

Key information

Recent management updates

Ever Supreme Bio Technology Co., Ltd Announces Members of the 3rd Remuneration Committee

Ever Supreme Bio Technology Co., Ltd, Annual General Meeting, Apr 30, 2024

Recent updates

Now 21% overvalued

Ever Supreme Bio Technology Co., Ltd to Report Q3, 2024 Results on Nov 04, 2024

Second quarter 2024 earnings released: EPS: NT$1.43 (vs NT$0.61 in 2Q 2023)

Ever Supreme Bio Technology Co., Ltd to Report Q2, 2024 Results on Aug 05, 2024

First quarter 2024 earnings released: EPS: NT$0.30 (vs NT$1.54 in 1Q 2023)

Dividend of NT$6.00 announced

Ever Supreme Bio Technology Co., Ltd Announces Members of the 3rd Remuneration Committee

Ever Supreme Bio Technology Co., Ltd to Report Q1, 2024 Results on May 08, 2024

Ever Supreme Bio Technology Co., Ltd to Report Q1, 2024 Results on May 08, 2024

Full year 2023 earnings released

Price target decreased by 10% to NT$206

Ever Supreme Bio Technology Co., Ltd, Annual General Meeting, Apr 30, 2024

Third quarter 2023 earnings released: EPS: NT$3.70 (vs NT$0.51 in 3Q 2022)

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: NT$0.68 (vs NT$0.56 in 2Q 2022)

New minor risk - Earnings quality

Upcoming dividend of NT$1.99 per share at 0.9% yield

Ever Supreme Bio Technology Co., Ltd Announces Cash Dividend, Payable on June 21, 2023

Full year 2022 earnings released: EPS: NT$2.95 (vs NT$5.45 in FY 2021)

Third quarter 2022 earnings released: EPS: NT$0.56 (vs NT$3.43 in 3Q 2021)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

First quarter 2022 earnings released: NT$0.15 loss per share (vs NT$0.22 loss in 1Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS NT$3.78 (vs NT$0.24 loss in 3Q 2020)

First quarter 2021 earnings released: NT$0.22 loss per share (vs NT$0.60 loss in 1Q 2020)

Full year 2020 earnings released: NT$1.91 loss per share (vs NT$1.68 loss in FY 2019)

Is Ever Supreme Bio Technology's (GTSM:6712) Share Price Gain Of 126% Well Earned?

New 90-day high: NT$267

New 90-day high: NT$250

We're Hopeful That Ever Supreme Bio Technology (GTSM:6712) Will Use Its Cash Wisely

New 90-day low: NT$173

New 90-day low: NT$178

If You Had Bought Ever Supreme Bio Technology (GTSM:6712) Shares A Year Ago You'd Have Earned 24% Returns

Third quarter 2020 earnings released: NT$0.24 loss per share

New 90-day high: NT$230

New 90-day high - NT$212

New 90-day high - NT$186

CEO